The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
Information about the talk, including continuing education, is available below.
For questions about this event or any others in the Discovery Series, please reach out to Mary Hindle at hindlem@health.missouri.edu
Advancing the University’s Research Mission through Multidisciplinarity in Biomedicine
In this presentation, Dr. Contag described the IQ and its formation, highlighted the science that has developed from the institute, and discussed best practices for building centers of excellence that extend the breadth and depth of Michigan State’s research and educational mission. The institute is devoted to basic and applied research at the interface of life sciences, engineering, information sciences, and other physical and mathematical sciences.
ÎçÒ¹Ó°Ôº the Speaker
Dr. Christopher Contag joined Michigan State University in 2017 as the founding director of the Institute for Quantitative Health Science and Engineering (IQ) and the inaugural chair of the new Department of Biomedical Engineering in the College of Engineering. He is also a professor in the Department of Microbiology and Molecular Genetics.
Continuing Professional Education Credit
Nurses
Up to 1.0 contact hour will be awarded to all participants who view the live sessions in their entirety and complete the evaluation form.
ÎçÒ¹Ó°Ôº is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Midwest Multistate Division Provider Number MO1022-6
Physicians
The , School of Medicine, ÎçÒ¹Ó°Ôº is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Office of Continuing Education, School of Medicine, ÎçÒ¹Ó°Ôº designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)â„¢. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
CONFLICT OF INTEREST: All persons with influence over the content of this program have been asked to disclose relevant financial interests in the last 12 months that might have an impact. John Spertus, MD, is a consultant for Jannsen, Bayer, Myokardia, Merck and Novartis, and receives research support from Abbott Vascular. No other speaker or planning committee member has a relevant financial interest.
Reviewed 2024-10-02